Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians

Gut

Volumn 48, Issue 4, 2001, Pages 461-467

  Carter, M J ^a   Di Giovine, F S ^a   Jones, S ^a   Mee, J ^a   Camp, N J ^a   Lobo, A J ^b   Duff, G W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Cytokine gene polymorphisms; Genetics; Inflammatory bowel disease; Interleukin 1; Interleukin 1 receptor antagonist; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADOLESCENT; ADULT; AGED; ALLELISM; ARTICLE; CHILD; CLINICAL TRIAL; COLON RESECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CONFIDENCE INTERVALS; FEMALE; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NORTHERN IRELAND; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1;

EID: 0035083730     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.4.461     Document Type: Article

References (48)

1. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking
2. Familial occurrence of inflammatory bowel disease
3. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregational analysis
4. The genetics of inflammatory bowel disease
5. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12
6. Mapping of a susceptibility locus for Crohn's disease on chromosome 16
7. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations
8. The role of interleukin-1 in disease
9. Interleukin-1 receptor antagonist
10. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta and interleukin-1 receptor antagonist genes
11. Interleukin-1 (IL-1) gene expression, synthesis and effect of specific IL-1 receptor blockade in rabbit immune complex colitis
12. Tissue interleukin-1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats
13. Role of interleukin-1 in inflammatory bowel disease - Enhanced production during active disease
14. Enhanced production of interleukin-1 beta by mononuclear cells isolated from the mucosa with active ulcerative colitis of Crohn's disease
15. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease: A novel mechanism of chronic intestinal inflammation
16. Colonic mucosal interleukin-1 receptor antagonist in inflammatory bowel disease
17. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis
18. Functions of interleukin-1 receptor antagonist in gene knockout and overproducing mice
19. Neutralisation of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis
20. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat
21. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment
22. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informity
23. Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist
24. Functional and ethnic association of allele 2 of IL-1 receptor antagonist gene in ulcerative colitis
25. Association between ulcerative colitis and a polymorphism in intron 2 of the interleukin-1 receptor antagonist gene
26. Cytokine gene polymorphisms in inflammatory bowel disease
27. Evidence for genetic heterogeneity in IBD: The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis
28. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis
29. Significance of interleukin-1 beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel disease
30. Association of HLA-DR15, P-ANCA and IL-1 receptor antagonist allele 2 with ulcerative colitis
31. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease
32. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology initiative
33. A simple salting out procedure for extracting DNA from human nucleated cells
34. Genetic markers may predict disease behaviour in patients with ulcerative colitis
35. Genetic and immunological markers in pouchitis
36. From genotypes to genes: Doubling the sample size
37. Statistical aspects of the analysis of data from retrospective studies of disease
38. Minimum expected cell size requirements for the Mantel-Haenszel one-degree-of-freedom chi-square test and related rapid procedure
39. On estimating the relation between blood group and disease
40. The TDT and other family-based tests for linkage disequilibrium and association
41. The future of genetic studiesof complex human diseases
42. Medical progress: Inflammatory bowel disease (part 2)
43. Genetics and genetic markers in inflammatory bowel disease
44. Clinical patterns, natural history, and progression of ulcerative colitis: A long-term follow-up of 1116 patients
45. Change in extent of colonic involvement in ulcerative colitis: A colonoscopic study
46. Imbalance of the interleukin-1 system in colonic mucosa - Association with intestinal inflammation and interleukin-1 receptor antagonist genotype 2
47. An analysis of linkage disequilibrium in the interleukin-1 gene cluster using a novel grouping method for multi-allelic markers
48. Four new members expand the interleukin-1 superfamily